Body-mass Index and Mortality Among 1.46 Million White Adults

Background: A high body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) is associated with increased mortality from cardiovascular disease and certain cancers, but the precise relationship between BMI and all-cause mortality remains uncertain.

Methods: We used Cox regression to estimate hazard ratios and 95% confidence intervals for an association between BMI and all-cause mortality, adjusting for age, study, physical activity, alcohol consumption, education, and marital status in pooled data from 19 prospective studies encompassing 1.46 million white adults, 19 to 84 years of age (median, 58).

Results: The median baseline BMI was 26.2. During a median follow-up period of 10 years (range, 5 to 28), 160,087 deaths were identified. Among healthy participants who never smoked, there was a J-shaped relationship between BMI and all-cause mortality. With a BMI of 22.5 to 24.9 as the reference category, hazard ratios among women were 1.47 (95 percent confidence interval [CI], 1.33 to 1.62) for a BMI of 15.0 to 18.4; 1.14 (95% CI, 1.07 to 1.22) for a BMI of 18.5 to 19.9; 1.00 (95% CI, 0.96 to 1.04) for a BMI of 20.0 to 22.4; 1.13 (95% CI, 1.09 to 1.17) for a BMI of 25.0 to 29.9; 1.44 (95% CI, 1.38 to 1.50) for a BMI of 30.0 to 34.9; 1.88 (95% CI, 1.77 to 2.00) for a BMI of 35.0 to 39.9; and 2.51 (95% CI, 2.30 to 2.73) for a BMI of 40.0 to 49.9. In general, the hazard ratios for the men were similar. Hazard ratios for a BMI below 20.0 were attenuated with longer-term follow-up.

Conclusions: In white adults, overweight and obesity (and possibly underweight) are associated with increased all-cause mortality. All-cause mortality is generally lowest with a BMI of 20.0 to 24.9.

Citing Articles

Body Mass Index and Cardiovascular Risk Markers: A Large Population Analysis.

Asztalos B, Russo G, He L, Diffenderfer M Nutrients. 2025; 17(5).

PMID: 40077610 PMC: 11902009. DOI: 10.3390/nu17050740.

The Effects of Sika Deer Antler Peptides on 3T3-L1 Preadipocytes and C57BL/6 Mice via Activating AMPK Signaling and Gut Microbiota.

Sun T, Hao Z, Meng F, Li X, Wang Y, Zhu H Molecules. 2025; 30(5).

PMID: 40076396 PMC: 11901460. DOI: 10.3390/molecules30051173.

Body weight in systemic lupus erythematosus is associated with disease activity and the adaptive immune system, independent of type I IFN.

Teruya H, Shoda H, Itamiya T, Tsuchida Y, Okamura T, Fujio K Front Immunol. 2025; 16:1503559.

PMID: 40040694 PMC: 11876045. DOI: 10.3389/fimmu.2025.1503559.

An Ethnobotanical Survey and Pharmacological and Toxicity Review of Medicinal Plants Used in the Management of Obesity in the North Central Zone of Nigeria.

Anyanwu G, Anzaku D, Bulus Y, Girgi J, Donwell C, Ihuma J J Obes. 2025; 2025:5568216.

PMID: 40026359 PMC: 11870763. DOI: 10.1155/jobe/5568216.

Physical activity, cardiovascular disease, and mortality across obesity levels.

Tian Q, Chen S, Liu S, Li Y, Wu S, Wang Y EPMA J. 2025; 16(1):51-65.

PMID: 39991104 PMC: 11842671. DOI: 10.1007/s13167-025-00397-5.

References

Schairer C, Byrne C, Keyl P, Brinton L, Sturgeon S, Hoover R . Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control. 1994; 5(6):491-500. DOI: 10.1007/BF01831376. View

Comstock G, Alberg A, Huang H, Wu K, Burke A, Hoffman S . The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev. 1997; 6(11):907-16. View

Flegal K, Graubard B, Williamson D, Gail M . Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007; 298(17):2028-37. DOI: 10.1001/jama.298.17.2028. View

Ogden C, Carroll M, Curtin L, McDowell M, Tabak C, Flegal K . Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295(13):1549-55. DOI: 10.1001/jama.295.13.1549. View

Weiderpass E, Braaten T, Magnusson C, Kumle M, Vainio H, Lund E . A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13(7):1121-7. View

Wolk A, Larsson S, Johansson J, Ekman P . Long-term fatty fish consumption and renal cell carcinoma incidence in women. JAMA. 2006; 296(11):1371-6. DOI: 10.1001/jama.296.11.1371. View

Beeson W, Mills P, Phillips R, Andress M, Fraser G . Chronic disease among Seventh-day Adventists, a low-risk group. Rationale, methodology, and description of the population. Cancer. 1989; 64(3):570-81. DOI: 10.1002/1097-0142(19890801)64:3<570::aid-cncr2820640303>3.0.co;2-4. View

Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J . Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373(9669):1083-96. PMC: 2662372. DOI: 10.1016/S0140-6736(09)60318-4. View

Alavanja M, Sandler D, McMaster S, Zahm S, McDonnell C, Lynch C . The Agricultural Health Study. Environ Health Perspect. 1996; 104(4):362-9. PMC: 1469343. DOI: 10.1289/ehp.96104362. View

10.

Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross P, Peel D . High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control. 2002; 13(7):625-35. DOI: 10.1023/a:1019552126105. View

11.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

12.

Takkouche B, Cadarso-Suarez C, Spiegelman D . Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol. 1999; 150(2):206-15. DOI: 10.1093/oxfordjournals.aje.a009981. View

13.

Manson J, Bassuk S, Hu F, Stampfer M, Colditz G, Willett W . Estimating the number of deaths due to obesity: can the divergent findings be reconciled?. J Womens Health (Larchmt). 2007; 16(2):168-76. DOI: 10.1089/jwh.2006.0080. View

14.

Moore S, Mayne S, Graubard B, Schatzkin A, Albanes D, Schairer C . Past body mass index and risk of mortality among women. Int J Obes (Lond). 2008; 32(5):730-9. PMC: 3051416. DOI: 10.1038/sj.ijo.0803801. View

15.

Baik I, Ascherio A, Rimm E, Giovannucci E, Spiegelman D, Stampfer M . Adiposity and mortality in men. Am J Epidemiol. 2000; 152(3):264-71. DOI: 10.1093/aje/152.3.264. View

16.

Andriole G, Crawford E, Grubb 3rd R, Buys S, Chia D, Church T . Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360(13):1310-9. PMC: 2944770. DOI: 10.1056/NEJMoa0810696. View

17.

Orsini N, Bellocco R, Bottai M, Pagano M, Michaelsson K, Wolk A . Combined effects of obesity and physical activity in predicting mortality among men. J Intern Med. 2008; 264(5):442-51. DOI: 10.1111/j.1365-2796.2008.01985.x. View

18.

Schatzkin A, Subar A, Thompson F, Harlan L, Tangrea J, Hollenbeck A . Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001; 154(12):1119-25. DOI: 10.1093/aje/154.12.1119. View

19.

Hu F, Willett W, Li T, Stampfer M, Colditz G, Manson J . Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med. 2004; 351(26):2694-703. DOI: 10.1056/NEJMoa042135. View

20.

Hayes R, Reding D, Kopp W, Subar A, Bhat N, Rothman N . Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials. 2001; 21(6 Suppl):349S-355S. DOI: 10.1016/s0197-2456(00)00101-x. View